Cefoperazone/sulbactam (CSL) and piperacillin/tazobactam (TZP) are commonly used in clinical practice in China because of their excellent antimicrobial activity. CSL and TZP-nonsusceptible Enterobacteriaceae are typically resistant to extended-spectrum cephalosporins such as ceftriaxone (CRO). However, 11 nonrepetitive Enterobacteriaceae strains, which were resistant to CSL and TZP yet susceptible to CRO, were collected from January to December 2020. Antibiotic susceptibility tests and whole-genome sequencing were conducted to elucidate the mechanism for this rare phenotype. Antibiotic susceptibility tests showed that all isolates were amoxicillin/clavulanic-acid resistant and sensitive to ceftazidime, cefepime, cefepime/tazobactam, cefepime/zidebactam, ceftazidime/avibactam, and ceftolozane/tazobactam. Whole-genome sequencing revealed three of seven Klebsiella pneumoniae strains harbored bla
SHV-1 only, and four harbored bla
SHV-1 and bla
TEM-1B. Two Escherichia coli strains carried bla
TEM-1B only, while two Klebsiella oxytoca isolates harbored bla
OXY-1-3 and bla
OXY-1-1, respectively. No mutation in the β-lactamase gene and promoter sequence was found. Outer membrane protein (Omp) gene detection revealed that numerous missense mutations of OmpK36 and OmpK37 were found in all strains of K. pneumoniae. Numerous missense mutations of OmpK36 and OmpK35 and OmpK37 deficiency were found in one K. oxytoca strain, and no OmpK gene was found in the other. No Omp mutations were found in E. coli isolates. These results indicated that narrow spectrum β-lactamases, TEM-1, SHV-1, and OXY-1, alone or in combination with Omp mutation, contributed to the resistance to CSL and TZP in CRO-susceptible Enterobacteriaceae.
Antibiotic susceptibility tests
Antibiotics
Breakpoint, (μg/ml)
Klebsiella pneumoniae
Escherichia cou
Klebriehd axyoca
E1
E3
E4
E7
E9
E10
E11
E6
E8
E2
E5
CRO
≤1≥4
≤0.5
≤0.5
≤0.5
≤0.5 1
≤0.5
1
≤0.5
≤0.5
1
1
CAZ
4 ≥16
1
2
1
4
4
4
4
2
4
1 1
FEP
≤2 216 1
1
0.25
1
2
2
2
0.5
2
1 1
AMC
≤8 ≥32
≥128
≥128
≥128
≥128
≥128
≥128
≥128
≥128
≥128
≥128
≥128
CSL
≤16 ≥64
64
64
64
64
≥128
128
≥128
64
128
128
≥128
TZP
≤16 ≥128
≥256
≥256
≥256
≥256
2256
2256
≥256
≥256
≥256
≥256
≥256
FPT
≤2 ≥16
1
0.5
0.06
0.125
2
1
2
0.25
1
0.125
0.25
FPZ
≤2 216
0.25
0.25
0.06
0.125
0.25
0.25 1
0.125
0.25
0.125
0.125
CZA
≤8 216 1
0.5
0.25
0.25
1
0.25
1
0.5
0.5
0.5
0.25
CZT
≤2 28
2
1
0.5 1
2
2
2 1
1
2
2
CROceftriaxone, CAZceftazidime, FEPcefepime, AMC:amoxicillin clavulanic-acid, CSLcefoperazone/sulbactam, TZP:piperadllin/tazobactam, FPT:cefepime tazobactam, FPZ:cefepime/zidebactam, CZA:ceftazidime/avibactam, CZTceftolozane/tazobactam
Gene sequencing results
Number
Strain
ST
p-Lactamase gene
Promoter sequence mutation
Omp mutation
El
Kpn
45
blaSHV-1, blaTEM-lB
none
OmpK36, OmpK3 7
E3
Kpn
45
blaSHV-1, blaTEM-lB
none
OmpK36. OmpK3 7
E4
Kpn
2854
blaSHV-1
none
OmpK36, OmpK3 7
E7
Kpn
2358
blaSHV-1 - blaTEM-lB
none
OmpK36, OmpK3 7
E9
Kpn
2358
blaSHV-1. blaTEM-lB
none
OmpK36. OmpK3 7
E10
Kpn 18
9
blaSHV-1
none
OmpK36. OmpK3 7
<